Current Oncology Reports

Papers
(The TQCC of Current Oncology Reports is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review149
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain145
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer99
New Developments in VHL-Associated Neuroendocrine Neoplasms98
Management of Upper Tract Urothelial Carcinoma76
NRG1 Fusions: The New Kid on the Block74
Immunotherapy in Biliary Tract Cancers: Where Are We?63
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review60
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas56
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers50
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors46
Brain Prehabilitation for Oncologic Surgery44
Treatment of Metastatic Melanoma in the Elderly41
Surgical Management of Melanoma: Advances and Updates40
New Insights on Tramadol and Immunomodulation38
Fatty Acid Metabolism and Cancer Immunotherapy38
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances37
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications37
Management of In-Transit Metastases36
Current Trends and Challenges of Microbiome Research in Prostate Cancer35
An Overview of Angiogenesis in Bladder Cancer34
Surgical Stress and Cancer Progression: New Findings and Future Perspectives33
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan32
The Microbiome in Advanced Melanoma: Where Are We Now?32
Head and Neck Mucosal Melanoma: Where Are We Now?32
Cellular Therapy in NSCLC: Between Myth and Reality32
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients31
Engineered T Cells: CAR T Cell Therapy and Beyond30
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites29
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting29
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications29
The Difficult Airway in Patients with Cancer28
AXL Inhibitors: Status of Clinical Development27
Anti-PD-1: When to Stop Treatment27
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients26
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations26
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review26
Cancer Pain Management—New Therapies26
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?26
Targeting the PI3K Pathway in Gynecologic Malignancies25
Proton Therapy in The Treatment of Head And Neck Cancers- Review25
Appendiceal Neuroendocrine Neoplasms: an Update for 202325
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours25
What Is the Status of Immunotherapy in Neuroendocrine Neoplasms?24
CAR-T Therapies in Solid Tumors: Opportunities and Challenges24
Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell Tumors24
Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy24
Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews23
Treatments on the Horizon: Breast Cancer Patients with Central Nervous System Metastases22
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer22
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question22
Surgery for Recurrent Epithelial Ovarian Cancer22
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma22
Current Management of Neuroendocrine Tumour Liver Metastases22
Pitfalls and Successes in Trials in Older Transplant Patients with Hematologic Malignancies22
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review21
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations20
Development of Effective Siglec-9 Antibodies Against Cancer20
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)20
Geographical Disparities in Colorectal Cancer in Canada: A Review20
Evolving Treatment Approaches to Mucosal Melanoma20
Critical Review of the Current Evidence on Sentinel Node Biopsy in Oral Cancer20
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing20
Helping Patients Understand and Cope with BRCA Mutations20
Controversies in the Treatment of Adolescents and Young Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia19
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions19
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials19
Vascular Inflammation, Cancer, and Cardiovascular Diseases19
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?18
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets18
Current Diagnostic Tools for Breast Cancer-Related Lymphedema18
Small Cell and Other Rare Histologic Types of Cervical Cancer18
Cardioprotection for Anti-HER2 Therapy: Considerations for Primary Prevention and Use in Mildly Reduced Left Ventricular Ejection Fraction18
Rehabilitation in Advanced Cancer Patients with Bone Metastases and Neural Compromise: Current Status and Future Directions17
The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging17
Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review17
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer17
Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity17
Elderly Rectal Cancer: An Updated Review17
Management of Peripheral T-cell Lymphomas and the Role of Transplant17
Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic17
Ependymoma: Evaluation and Management Updates17
Current Status on Management of Primary Plasma Cell Leukemia16
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review16
Statins for Cardiac and Vascular Protection During and After Cancer Therapy16
History of Leukemia, Revisited16
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights16
Epidemiology of Cancer in Older Adults: A Systematic Review16
Intratumoral Immunotherapy: Is It Ready for Prime Time?16
Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review16
Multimodality Therapies for Localized Prostate Cancer16
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis15
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives15
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment15
Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy15
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours15
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy15
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers15
Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge14
Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies14
Richter’s Transformation14
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development14
Return to Intended Oncological Therapy: State of the Art and Perspectives14
Bystander effect of antibody–drug conjugates: fact or fiction?14
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment14
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions14
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade14
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma14
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer13
All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations13
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?13
Interventional Strategies in Cancer-induced Cardiovascular Disease13
Is Myelodysplasia a Consequence of Normal Aging?13
CDK4/6 inhibitors: The Devil is in the Detail13
Lymphatic Interventions in the Cancer Patient13
Viral and Clinical Oncology of Head and Neck Cancers13
The Role and Impact of Minimal Residual Disease in NSCLC13
Racial Disparities in Breast Cancer: from Detection to Treatment13
Cardio-Oncology in Childhood: State of the Art13
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas13
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL13
Clinicopathological Review of Micropapillary Urothelial Carcinoma12
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer12
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine12
Advances in Treatment of Waldenström Macroglobulinemia12
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis12
Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers12
Current Role of Functional Imaging in the Management of Lymphoma12
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway12
Traditional Chinese Medicine Herbs for Breast Cancer Prevention and Survival: A Narrative Review of Epidemiological Studies from Taiwan12
Treatment of Primary CNS Lymphoma: Maximizing Clinical Benefit, Minimizing Neurotoxicity12
Epidemiology of cancer in older adults: a systematic review of age-related differences in solid malignancies treatment12
Correction: Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science12
CAR T-cell Therapy for Central Nervous System Lymphoma12
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer12
Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer12
Surviving Burnout as an Oncologist12
Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer12
0.070327043533325